Gene | Protein | |
---|---|---|
BTK | Tyrosine-protein kinase BTK | |
CDK2 | Cyclin-dependent kinase 2 | |
CDK5 | Cyclin-dependent-like kinase 5 | |
CK2 | Casein kinase II subunit alpha | |
CLK3 | Dual specificity protein kinase CLK3 | |
DAPK3 | Death-associated protein kinase 3 | |
DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | |
EPHA7 | Ephrin type-A receptor 7 | |
ERBB2 | HER2, Receptor tyrosine-protein kinase erbB-2, extracellular domain | |
FGFR1 | Fibroblast growth factor receptor 1 | |
LATS2 | Serine/threonine-protein kinase LATS2 | |
MAP2K4 | Dual specificity mitogen-activated protein kinase kinase 4 | |
PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | |
PIM1 | Serine/threonine-protein kinase pim-1 | |
PIM3 | Serine/threonine-protein kinase pim-3 | |
PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | |
PLK4 | Serine/threonine-protein kinase PLK4 | |
RSK1 | RPS6KA1 Ribosomal protein S6 kinase alpha-1 | |
STK10 | LOK or Serine/threonine-protein kinase 10 | |
STK17A | DRAK1 or Serine/threonine-protein kinase 17A | |
STK17B | DRAK2 or Serine/threonine-protein kinase 17B | |
Vps34 | PIK3C3 Phosphatidylinositol 3-kinase catalytic subunit type 3 | |
Gene | Protein | |
---|---|---|
DPP4 | Dipeptidyl peptidase 4 | |
Thrombin | F2, Human alpha thrombin | |
PTPN1 | PTP1B, Tyrosine-protein phosphatase non-receptor type 1 | |
SHP2 | PTPN11, Tyrosine-protein phosphatase non-receptor type 11 | |
USP21 | UBP21, Ubiquitin carboxyl-terminal hydrolase 21 | |
USP7 | UBP7, Ubiquitin carboxyl-terminal hydrolase 7 | |
USP8 | UBP8, Ubiquitin carboxyl-terminal hydrolase 8 | |
Gene | Protein | |
---|---|---|
Aldose reductase | ALDR, Aldose reductase | |
BCAT2 | Branched-chain-amino-acid aminotransferase, mitochondrial | |
BCL2A1 | BFL1, Bcl-2-related protein A1 | |
BSSL | Bile salt-activated lipase | |
CathepsinC | CPPI, Dipeptidyl peptidase 1 | |
CD137 | TNFRSF9, Tumor necrosis factor receptor superfamily member 9 | |
CD47 | Leukocyte surface antigen CD47 | |
CGAS | Cyclic GMP-AMP synthase | |
CYP51A1 | Lanosterol 14-alpha demethylase | |
DHODH | Dihydroorotate dehydrogenase | |
EIF4E | Eukaryotic translation initiation factor 4E | |
Gal-3C | LGALS3, Galectin-3 C-terminal carbohydrate binding domain | |
Gal-8N | LGALS8, Galectin 8 N-terminal carbohydrate binding domain | |
GART | Trifunctional purine biosynthetic protein adenosine-3 | |
GMPR2 | GMP reductase 2 | |
GP6 | Platelet glycoprotein VI | |
HSP90AA1 | Heat shock protein HSP 90-alpha | |
IL17A | IL-17A, Interleukin-17A | |
IL23A | IL-23A, Interleukin-23, subunits alpha and beta | |
CXCL8 | IL-8, Interleukin-8 | |
LDHA | LDHA, L-lactate dehydrogenase A chain (rabbit) | |
NRP1 | Neuropilin-1 | |
PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | |
PSD95 | DLG4, Disks large homolog 4 | |
RORC | Nuclear receptor ROR-gamma | |
S100A12 | Protein S100-A12 | |
S100A4 | Mts1 or Protein S100-A4 | |
S100A9t | MRP14, Protein S100-A9 | |
TIM-3 | HAVCR2 , Hepatitis A virus cellular receptor 2 | |
F3 | TF, Tissue factor | |
TNF-alpha | Tumor necrosis factor | |
TUBA1A | Tubulin alpha-1A (pig) | |
UBA52 | Ubiquitin-60S ribosomal protein L40 | |
Gene | Protein | |
---|---|---|
blaC | Beta-lactamase (M. tuberculosis) | |
gyrB | DNA gyrase subunit B (S. aureus) | |
Snf | LeuT, Na(+):neurotransmitter symporter, Snf family (Aquifex aeolicus VF5) | |
SARS CoV-2 RBD | Spike glycoprotein receptor-binding domain (SARS-CoV-2) | |
SARS CoV-2 RBD beta | Spike glycoprotein receptor-binding domain, B.1.351 variant (SARS-CoV-2) | |
On the image: Björn Walse, PhD, CEO SARomics Biostructures, and Raymond Kimbung, PhD, Senior Scientist, Team Leader, Protein Production